PT  - JOURNAL ARTICLE
AU  - PR Scully
AU  - E Morris
AU  - M Burniston
AU  - TA Treibel
AU  - M Jerrum
AU  - K Bedford
AU  - H Queenan
AU  - N Hartman
AU  - M Mullen
AU  - M Ozkor
AU  - S Kennon
AU  - J Newton
AU  - N Sabharwal
AU  - A Kelion
AU  - PM Elliott
AU  - JC Moon
AU  - PN Hawkins
AU  - LJ Menezes
TI  - 3 SPECT/CT quantification of DPD scintigraphy in cardiac amyloid
AID  - 10.1136/heartjnl-2018-BCVI.44
DP  - 2018 May 01
TA  - Heart
PG  - A16--A16
VI  - 104
IP  - Suppl 5
4099  - http://heart.bmj.com/content/104/Suppl_5/A16.2.short
4100  - http://heart.bmj.com/content/104/Suppl_5/A16.2.full
SO  - Heart2018 May 01; 104
AB  - Introduction 99mTc-3,3-diphosphono-1,2-propanodicarboxylic acid (DPD) scintigraphy offers a sensitive, non-invasive test for cardiac transthyretin amyloid. The Perugini grading system relies on a visual score of the planar image – from grade 0 (negative) to 3 (strongly positive). SPECT allows the 3D visualisation of radioactivity within the body. SPECT/CT quantification may improve diagnostic accuracy and offer a means of measuring amyloid burden.Methods The software algorithm (Hermes Medical) converts recorded counts per voxel into activity per unit volume, enabling quantitative reconstructions and display of standardised uptake values (SUV). Volumes of interest were placed over the heart, adjacent vertebra, paraspinal muscle and liver and peak SUV (SUVpeak) recorded. P-values were calculated using a one-way ANOVA.Results We identified 32 patients (aged 82±9 years, 59% male), with a range of DPD results (10 grade 0, 6 grade 1, 12 grade 2, 4 grade 3). Cardiac SUVpeak increased from Perugini grade 0 to 2, but plateaued at 3 (1.39±0.47 vs 3.82±1.66 vs 12.89±4.39 vs 10.79±1.12; p<0.001).Vertebral SUVpeak decreased from Perugini grade 0 to 3 (11.75±3.79 vs 9.60±2.28 vs 8.34±2.25 vs 5.85±1.53; p<0.006). Paraspinal muscle SUVpeak increased from Perugini grade 0 to 3 (0.50±0.13 vs 0.57±0.13 vs 0.76±0.27 vs 1.29±0.24; p<0.001). Liver SUVpeak did not vary between grades (p=0.952). On ROC analysis, a cardiac SUVpeak of 2.3 diagnosed amyloidosis with 95% sensitivity and 90% specificity.Conclusion SPECT/CT quantification in DPD scintigraphy has diagnostic and discriminatory power. Competition for tracer between skeletal muscle and the heart in grade 3 cases may confound quantification of cardiac amyloid burden.